{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:42:46Z","timestamp":1793731366260,"version":"4.6.1"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014468","name":"Mallinckrodt Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014468","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Allograft rejection is a critical issue following solid organ transplantation (SOT). Immunosuppressive therapies are crucial in reducing risk of rejection yet are accompanied by several significant side effects, including infection, malignancy, cardiovascular diseases, and nephrotoxicity. There is a current unmet medical need with a lack of effective minimization strategies for these side effects. Extracorporeal photopheresis (ECP) has shown potential as an immunosuppression (IS)-modifying technique in several SOT types, with improvements seen in acute and recurrent rejection, allograft survival, and associated side effects, and could fulfil this unmet need. Through a review of the available literature detailing key areas in which ECP may benefit patients, this review highlights the IS-modifying potential of ECP in the four most common SOT procedures (heart, lung, kidney, and liver transplantation) and highlights existing gaps in data. Current evidence supports the use of ECP for IS modification following SOT, however there is a need for further high-quality research, in particular randomized control trials, in this area.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1371554","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T08:37:10Z","timestamp":1716453430000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical need"],"prefix":"10.3389","volume":"15","author":[{"given":"Jean-Fran\u00e7ois","family":"Augusto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Benden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Diekmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"a014985","DOI":"10.1101\/cshperspect.a014985","article-title":"Why is organ transplantation clinically important","volume":"3","author":"Griny\u00f3","year":"2013","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B2","unstructured":"Transplant Immunology Policy Briefing2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1432-2277.2006.00440.x","article-title":"Quality of life following organ transplantation","volume":"20","author":"Burra","year":"2007","journal-title":"Transplant Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000542650.33995.b3","article-title":"Worldwide distribution of solid organ transplantation and access of population to those practices","volume":"102","author":"Mahillo","year":"2018","journal-title":"Transplantation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-1755.2005.00376.x","article-title":"Chronic renal allograft rejection: pathophysiologic considerations","volume":"68","author":"Joosten","year":"2005","journal-title":"Kidney Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200010150-00018","article-title":"Increased impact of acute rejection on chronic allograft failure in recent era","volume":"70","author":"Meier-Kriesche","year":"2000","journal-title":"Transplantation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","article-title":"Mechanisms of rejection: current perspectives","volume":"93","author":"Wood","year":"2012","journal-title":"Transplantation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD012854","article-title":"Interventions for improving medication adherence in solid organ transplant recipients","volume":"2017","author":"Mellon","year":"2017","journal-title":"Cochrane Database Systematic Rev"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-018-05515-8","volume-title":"Initial Immunosuppression and Managing Rejection","author":"Fuehner","year":"2019"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000149745.83186.89","article-title":"Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200507-073JS","article-title":"Transplant-related immunosuppression: A review of immunosuppression and pulmonary infections","volume":"2","author":"Duncan","year":"2005","journal-title":"Proc Am Thorac Society"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20199","article-title":"Photopheresis therapy for problematic renal allograft rejection","volume":"24","author":"Jardine","year":"2009","journal-title":"J Clin Apheresis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0041-1345(00)02605-1","article-title":"Photopheresis immunomodulation after heart transplantation","volume":"33","author":"Maccherini","year":"2001","journal-title":"Transplant Proc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.4254\/wjh.v7.i10.1355","article-title":"Review on immunosuppression in liver transplantation","volume":"7","author":"Moini","year":"2015","journal-title":"World J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3978\/j.issn.2072-1439.2014.04.23","article-title":"Immunosuppression in lung transplantation","volume":"6","author":"Scheffert","year":"2014","journal-title":"J Thorac Disease"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2021.101762","article-title":"Adverse effects of immunosuppression after liver transplantation","volume":"101762","author":"Noble","year":"2021","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001244","article-title":"Calcineurin inhibitor nephrotoxicity in the era of antibody-mediated rejection","volume":"100","author":"Naesens","year":"2016","journal-title":"Transplantation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13765","article-title":"Protecting the kidney in liver transplant recipients: practice-based recommendations from the American society of transplantation liver and intestine community of practice","volume":"16","author":"Levitsky","year":"2016","journal-title":"Am J Transpl"},{"key":"B20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/QCO.0000000000000488","article-title":"Multidrug-resistant Gram-negative infection in solid organ transplant recipients: implications for outcome and treatment","volume":"31","author":"Silva","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/tri.2017.30.issue-9","article-title":"Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study","volume":"30","author":"Oriol","year":"2017","journal-title":"Transpl Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/TP.0000000000002316","article-title":"Long-term challenges after solid organ transplantation: summary of expert presentations from the Sandoz 5th standalone transplantation meeting, 2017","volume":"102","author":"Legendre","year":"2018","journal-title":"Transplantation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/ajts.AJTS_87_16","article-title":"Extracorporeal photopheresis: review of technical aspects","volume":"11","author":"Arora","year":"2017","journal-title":"Asian J Transfusion Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00236","article-title":"Extracorporeal photopheresis\u2014An overview","volume":"5","author":"Cho","year":"2018","journal-title":"Front Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jdv.12311","article-title":"Guidelines on the use of extracorporeal photopheresis","volume":"28","author":"Knobler","year":"2014","journal-title":"J Eur Acad Dermatol Venereology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2014.04.006","article-title":"ECP and solid organ transplantation","volume":"50","author":"Jaksch","year":"2014","journal-title":"Transfusion Apheresis Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002168","article-title":"Extracorporeal photopheresis for bronchiolitis obliterans syndrome after lung transplantation","volume":"102","author":"Hachem","year":"2018","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells12182321","article-title":"What does the future hold for biomarkers of response to extracorporeal photopheresis for mycosis fungoides and s\u00e9zary syndrome","volume":"12","author":"Akilov","year":"2023","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.07.031","article-title":"Mechanistic insights into extracorporeal photochemotherapy: efficient induction of monocyte-to-dendritic cell maturation","volume":"50","author":"Edelson","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2014.04.003","article-title":"Updating ECP action mechanisms","volume":"50","author":"Heshmati","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v10i34","article-title":"Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma","volume":"10","author":"Ying","year":"2019","journal-title":"Oncotarget"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz1580","article-title":"Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes","volume":"6","author":"Han","year":"2020","journal-title":"Sci Adv"},{"key":"B34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jdermsci.2006.05.004","article-title":"Extracorporeal photopheresis: a focus on apoptosis and cytokines","volume":"43","author":"Bladon","year":"2006","journal-title":"J Dermatol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812103392404","article-title":"Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis transplantation study group","volume":"339","author":"Barr","year":"1998","journal-title":"New Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199507150-00009","article-title":"Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection","volume":"60","author":"Dall'Amico","year":"1995","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10320","DOI":"10.3389\/ti.2022.10320","article-title":"Extracorporeal photopheresis with low-dose immunosuppression in high-risk heart transplant patients-A pilot study","volume":"35","author":"G\u00f6kler","year":"2022","journal-title":"Transpl Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2017.07.009","article-title":"Extracorporeal photochemotherapy in heart transplant rejection: A single-center experience","volume":"56","author":"Savignano","year":"2017","journal-title":"Transfusion Apheresis Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2023.03.005","article-title":"European multicenter study on the real-world use and clinical impact of extracorporeal photopheresis after heart transplantation","volume":"42","author":"Barten","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199910150-00027","article-title":"Extracorporeal photochemotherapy for Epstein-Barr virus-associated lymphoma after lung transplantation","volume":"68","author":"Schoch","year":"1999","journal-title":"Transplantation"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31818bc024","article-title":"Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience","volume":"86","author":"Benden","year":"2008","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13145","article-title":"Extracorporeal photopheresis as second-line treatment therapy in life-threatening primary graft dysfunction following lung transplantation","volume":"22","author":"Robinson","year":"2018","journal-title":"Pediatr Transpl"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21831","article-title":"ECP as additional immunomodulation in idiopathic hyperammonemia and recurrent hypercapnic respiratory failure early post lung transplantation","volume":"36","author":"Steinack","year":"2020","journal-title":"J Clin apheresis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.resmer.2022.100913","article-title":"Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience","volume":"81","author":"Leroux","year":"2022","journal-title":"Respir Med Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V91121","article-title":"Successful treatment of recurrent rejection in renal transplant patients with photopheresis","volume":"9","author":"Dall'Amico","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000147197.24050.61","article-title":"Photopheresis for the treatment of refractory renal graft rejection","volume":"79","author":"Kumlien","year":"2005","journal-title":"Transplantation"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2019.06.031","article-title":"Extracorporeal photopheresis for the treatment of graft rejection in 33 adult kidney transplant recipients","volume":"58","author":"Tamain","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/tri.14006","article-title":"Successful treatment of acute kidney allograft rejection using extracorporeal photopheresis in the context of post-transplant lymphoproliferative diseases: three successive cases","volume":"34","author":"Augusto","year":"2021","journal-title":"Transplant Int"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20111","article-title":"Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: the role of extracorporeal photopheresis","volume":"22","author":"Urbani","year":"2007","journal-title":"J Clin Apheresis"},{"key":"B50","unstructured":"The Oxford 2011 Levels of Evidence: Oxford Centre for Evidence-Based Medicine2011"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report\u20142019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2133.2005.06857.x","article-title":"Evidence-based practice of photopheresis 1987\u20132001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group","volume":"154","author":"McKenna","year":"2006","journal-title":"Br J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/jdv.16889","article-title":"European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2","volume":"35","author":"Knobler","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The international society for heart and lung transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2217\/imt.14.69","article-title":"Extracorporeal photopheresis after heart transplantation","volume":"6","author":"Barten","year":"2014","journal-title":"Immunotherapy"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2005.10.004","article-title":"Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis","volume":"25","author":"Kirklin","year":"2006","journal-title":"J Heart Lung transplantation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment\u2015A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplantation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apher"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.08.029","article-title":"The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation","volume":"29","author":"Morrell","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13041","article-title":"Lung transplant recipients on long-term extracorporeal photopheresis","volume":"31","author":"Isenring","year":"2017","journal-title":"Clin Transplant"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12882-019-1672-8","article-title":"Treatment of chronic active antibody-mediated rejection in renal transplant recipients - a single center retrospective study","volume":"21","author":"Chiu","year":"2020","journal-title":"BMC Nephrol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.kint.2021.03.027","article-title":"Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy","volume":"100","author":"Kung","year":"2021","journal-title":"Kidney Int"},{"key":"B64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jca.21958","article-title":"Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series","volume":"37","author":"Xipell","year":"2022","journal-title":"J Clin Apher"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.028","article-title":"Indications for liver transplantation","volume":"134","author":"O'Leary","year":"2008","journal-title":"Gastroenterology"},{"key":"B66","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2008.03.071","article-title":"Potential applications of extracorporeal photopheresis in liver transplantation","volume-title":"Transplantation proceedings","author":"Urbani","year":"2008"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2017.07.008","article-title":"Extracorporeal photopheresis and liver transplantation: Our experience and preliminary data","volume":"56","author":"Mazzoni","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC)","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19912","article-title":"Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes","author":"Knobler","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19937","article-title":"Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema","author":"Knobler","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1371554\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T08:37:22Z","timestamp":1716453442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1371554\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":70,"alternative-id":["10.3389\/fimmu.2024.1371554"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1371554","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"article-number":"1371554"}}